Chron. com have published a good article entitled "Market Spotlight: Generic Drugs" Emboldened by favorable court rulings and the need to gain an early foothold in the market, generic drug developers are increasingly challenging lucrative drug patents.
In many cases those challenges have been coming in the form of at-risk launches, where a generic version of a patented drug is sold before the patent expires. Please read complete article on following link
In many cases those challenges have been coming in the form of at-risk launches, where a generic version of a patented drug is sold before the patent expires. Please read complete article on following link
